Net sales reached $5.34 billion, a 2% increase year-over-year, though organic sales declined by 1%. Operating profit fell 59% to $259 million, impacted by $108 million in restructuring costs. Net earnings attributable to common shareowners were $238 million, down from $412 million in Q1 2025. Diluted earnings per share (EPS) decreased to $0.28 from $0.47 in the prior year period. The company repurchased 5.0 million shares for $306 million during the quarter.